Quest Diagnostics Incorporated provides diagnostic testing and services in the United States and internationally. The company develops and delivers diagnostic information services, such as routine, non-routine and advanced clinical testing, anatomic pathology testing, and other diagnostic information services. It also provides diagnostic information services primarily under the Quest Diagnostics brand, as well as under the AmeriPath, Dermpath Diagnostics, ExamOne, and Quanum brands to physicians, hospitals, patients and consumers, health plans, government agencies, employers, emerging retail healthcare providers, pharmaceutical companies and insurers, commercial clinical laboratories, and accountable care organizations through a network of laboratories, patient service centers, phlebotomists in physician offices, call centers and mobile phlebotomists, nurses, and other health and wellness professionals. In addition, the company offers risk assessment services for the life insurance industry; and healthcare organizations and clinicians information technology solutions. Quest Diagnostics Incorporated was founded in 1967 and is headquartered in Secaucus, New Jersey.

Quest Diagnostics Incorporated

Mizuho Securities analyst Ann Hynes reiterated a Buy rating on Quest Diagnostics yesterday. The company’s shares closed yesterday at $185.96. Hynes...

Quest Diagnostics (DGX) Receives a Buy from Mizuho Securities

Digi Power X ( ($TSE:DGX) ) has issued an announcement. On November 18, 2025, Digi Power X Inc. announced the filing of an amended and restated pro...

Digi Power X Updates Equity Program with New Prospectus

Digihost Technology Inc ( ($DGXX) ) has released its Q3 earnings. Here is a breakdown of the information Digihost Technology Inc presented to its i...

Digi Power X Reports Positive Q3 Earnings and Strategic Growth

Digi Power X ( ($TSE:DGX) ) just unveiled an update. Digi Power X reported positive net earnings for Q3 2025, marking a significant turnaround from...

Digi Power X Achieves Profitability and Advances AI Infrastructure Plans

Dollar General ( ($DG) ) has shared an announcement. On November 12, 2025, Dollar General Corporation announced the appointment of Emily C. Taylor ...

Dollar General Appoints Emily C. Taylor as COO

An announcement from China Dongxiang (Group) Co ( ($HK:3818) ) is now available. China Dongxiang (Group) Co., Ltd. has announced a supplemental dis...

China Dongxiang Enhances Investment Strategy with RMB Fund Subscription

Digi Power X ( ($TSE:DGX) ) just unveiled an announcement. Digi Power X announced it will release its Q3 2025 financial results on November 13, 202...

Digi Power X to Release Q3 2025 Financial Results and Host Conference Call

In a report released today, Zhihan Ma from Bernstein maintained a Buy rating on Dollar General, with a price target of $134.00. The company’s share...

Bernstein Sticks to Their Buy Rating for Dollar General (DG)

Bernstein analyst Zhihan Ma maintained a Buy rating on Dollar General yesterday and set a price target of $134.00. The company’s shares closed yest...

Current Quarter	$2.36	Next Quarter	$2.35
Current Year	$9.79	Next Year	$10.37
QoQ Growth	-0.4%	YoY Growth	+5.9%
3Y EPS CAGR	-21.1%	Target Price	$198.71
Consensus	Buy	Upside	+3.9%

Current Quarter Rev	N/A	Next Quarter Rev	N/A
Revenue Growth	N/A	YoY Growth	N/A

	A	B	C	D
1	Symbol	Price	Change	Volume
2	DGX	$191.25	+1.94%	1.77M
3
4
5

	A	B	C	D
1	Symbol	Price	Change	Vol
2	DGX	$191.25	+1.9%	1.77M
3
4
5
6

DGX

DGX

EPS Estimates Overview

EPS Historical Trend (5 Years)

Quarterly EPS Estimates

Revenue Analysis

Get Quest Diagnostics Incorporated Data in Excel

Get Quest Diagnostics Incorporated Data in Excel